Cholinergic treatment strategies in Alzheimer's disease
Kurz, A.; Rüster, P.; Romero, B.; Zimmer, R.
Der Nervenarzt 57(10): 558-569
1986
ISSN/ISBN: 0028-2804 PMID: 3785472 Document Number: 269596
Document emailed within 1 workday
Related Documents
Lawrence, A.D.; Sahakian, B.J. 1995: Alzheimer disease, attention, and the cholinergic system Alzheimer Disease and Associated Disorders 9(Suppl 2): 43-49Bradley, R.J.; Edge, M.T.; Freeman, A.M. 1991: The effects of cholinergic preparations in Alzheimer's disease Farmakologiia i Toksikologiia 54(3): 4-10
Clader, J.W. 1999: Recent advances in cholinergic drugs for Alzheimer's disease Current Opinion in Drug Discovery and Development 2(4): 311-320
Tucek, S. 1987: Cholinergic mechanisms in the brain and their impairment in Alzheimer's disease Ceskoslovenska Psychiatrie 83(1): 36-45
Pomara, N.; Stanley, M. 1986: The cholinergic hypothesis of memory dysfunction in Alzheimer's disease--revisited Psychopharmacology Bulletin 22(1): 110-118
Robert, P.H.; Gokalsing, E.; Bertogliati, C. 1999: Cholinergic hypothesis and Alzheimer's disease: the place of donepezil (Aricept) L'Encephale 25(Special Issue 5): 23-27; Discussion: 28-29
Mukhin, V.N. 2013: Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 99(7): 793-804
Braginskaia, F.I.; Zorina, O.M.; Pal'mina, N.P.; Gaintseva, V.D.; Burlakova, E.B.; Selezneva, N.D.; Kolykhalov, I.V.; Gavrilova, S.I. 2000: Certain biochemical blood markers in the process of cholinergic therapy in Alzheimer's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(6): 29-32
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Williams, L.R.; Jodelis, K.S.; Donald, M.R. 1989: Regional stimulation of cholinergic function by nerve growth factor in an animal model of Alzheimer's disease Progress in Clinical and Biological Research 317: 1179-1192
Harbaugh, R.E. 1987: Intracerebroventricular cholinergic drug administration in Alzheimer's disease: preliminary results of a double-blind study Journal of Neural Transmission. Supplementum 24: 271-277
Fisher, A.; Brandeis, R.; Karton, I.; Pittel, Z.; Gurwitz, D.; Haring, R.; Sapir, M.; Levy, A.; Heldman, E. 1991: (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease Journal of Pharmacology and Experimental Therapeutics 257(1): 392-403
Lacomblez, L. 1998: Drug therapy strategies in Alzheimer's disease La Revue du Praticien 48(17): 1913-1917
Sugaya, K.; Alvarez, A.; Marutle, A.; Kwak, Y.D.; Choumkina, E. 2006: Stem cell strategies for Alzheimer's disease therapy Panminerva Medica 48(2): 87-96
Lansbury, P.T. 1995: Consequences of the molecular mechanism of amyloid formation for the understanding of the pathogenesis of Alzheimer's disease and the development of therapeutic strategies Arzneimittel-Forschung 45(3a): 432-434
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474